Ignite Creation Date:
2024-05-06 @ 3:58 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04825990
Status:
RECRUITING
Last Update Posted:
2022-04-07
First Post:
2021-03-29
Brief Title:
Pembrolizumab and Olaparib in RecurrentMetastatic Platinum Resistant Nasopharyngeal Cancer
Sponsor:
Organization:
Gruppo Oncologico del Nord-Ovest